Carnosol

Overview

Carnosol is a potent Ribosomal S6 Kinase ( RSK2 ) inhibitor that could be useful for treating gastric cancer , with an IC 50 of ~5.5 μM. Carnosol, a Nrf2 activator, increases the nuclear levels of Nrf2 and can promote the expression of heme oxygenase 1 (HMOX1).

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Ribosomal S6 Kinase (RSK) | Products > Signaling Pathways > Keap1-Nrf2 | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-N0643
• CAS No.: 5957-80-2
• Molecular Formula: C20H26O4
• Molecular Weight: 330.42
• Purity: 98.79%
• Storage: Powder -20°C, 3 years * The compound is unstable in solutions, freshly prepared is recommended.
• Solubility: ≥ 2.08 mg/mL (6.30 mM); Clear solution
• Availability: In-stock

Source

Original product source